06.09.2021 • News

Casale Wins Russian Melamine Project

Casale has signed a Memorandum of Understanding with Russia’s Metafrax Chemicals for the construction of a melamine plant. The facility will be built at Metrafrax’s site in Gubakha in Russia’s Perm region

Under the terms of the MoU, Casale will provide engineering, procurement and construction services on a turnkey basis, including plant design, supply of all equipment and materials, and commissioning, which is scheduled for 2024.

The unit will be integrated into Metafrax’s existing ammonia-urea-melamine (AUM) complex, which was also built by Casale and employs the Swiss firm’s technology. Current capacity at the complex is 300,000 t/y ammonia, 575,000 urea and 40,000 t/y melamine.

“The development of the AUM complex, which will finally include two melamine production units, is the result of a close cooperation with our partner Metafrax Chemicals,” said Casale CEO Federico Zardi, adding that the project also confirms its worldwide leadership in designing and constructing such plants.

Metafrax general director Vladimir Daut also commented: “With this investment we will become one of the largest producers of melamine in Europe, provide ourselves with raw materials for the expanding production of resins and create new high-tech jobs for residents.”

Separately, Casale has announced that it has won a contract to supply a new hydrolyser for a major European melamine producer. The hydrolyser, which will treat wastewater from two melamine plants, will replace two existing treatment units, which Casale said are based on obsolete technology that “makes them inadequate to the new environmental standards.”

Author: Elaine Burridge, Freelance Journalist

Casale has signed an agreement with Russia’s Metafrax Chemicals for the...
Casale has signed an agreement with Russia’s Metafrax Chemicals for the construction of a melamine plant at Gubakha in Russia’s Perm region. Casale will provide engineering, procurement and construction services on a turnkey basis, with startup scheduled for 2024. (c) Casale

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.